5-Fluorouracil → 1-(1-Hydroxymethylpropyloxy)-methyl-5-fluorouracil
反応式
[CH2:1]([CH:3]1[CH2:7][O:6]C[O:4]1)[CH3:2].[CH2:8](O)C(O)CC.C[Si]([C:18]1[NH:23][C:22](=[O:24])[N:21]([Si](C)(C)C)[C:20](=[O:29])[C:19]=1[F:30])(C)C.FC1C(=O)NC(=O)NC=1.C(=O)(O)[O-].[Na+]>C(Cl)(Cl)Cl.CO>[OH:6][CH2:7][CH:3]([O:4][N:23]1[CH:18]=[C:19]([F:30])[C:20](=[O:29])[N:21]([CH3:8])[C:22]1=[O:24])[CH2:1][CH3:2]参加物
実験手順
4-Ethyl-1,3-dioxolane (10 ml) prepared from butane-1,2-diol was added to bis(trimethylsilyl)-5-fluorouracil prepared from 5-fluorouracil (10 g) as in Example 1. To the mixture was added dropwise a solution of anhydrous stannic chloride (6 ml) in chloroform (15 ml) over one hour under cooling in an ice bath followed by stirring at room temperature for one hour. The reaction mixture was poured into methanol (100 ml) containing sodium bicarbonate (30 g), and after removing the resulting precipitate, the filtrate was evaporated under reduced pressure. The residue was dissolved in water (10 ml), purified by column chromatography with use of Amberlite XAD-4 (Rohm and Haas Co.), and treated with benzene to give 6.9 g of crystalline 1-(1-hydroxymethylpropyloxy)-methyl-5-fluorouracil.
後処理
- temperatureunder cooling in an ice bath
- customafter removing the resulting precipitate
- customthe filtrate was evaporated under reduced pressure
- dissolutionThe residue was dissolved in water (10 ml)
- custompurified by column chromatography with use of Amberlite XAD-4 (Rohm and Haas Co.)
- additiontreated with benzene
出典と根拠
- ORDレコード
- ord-86475d75c42945d7b6a596c5f8ea7110
- 出典データセット
- uspto-grants-1983_11
- 特許番号
- US04415573
反応ノート
読み込み中…